1 min read

Regulatory authorities around the world are increasingly adopting digital tools to improve regulatory efficiency, transparency, and traceability across the life sciences sector. Digital platforms can help streamline regulatory procedures while strengthening oversight of regulated products.

In Colombia, this digital transformation includes InvimÁgil, a platform developed by the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) to support the digitalization of regulatory processes for health products.

Understanding how this platform functions helps clarify how Colombia is modernizing regulatory management across multiple regulated sectors.

The Role of InvimÁgil in Colombia’s Regulatory System

InvimÁgil is a digital platform designed to facilitate the management of regulatory procedures administered by INVIMA. The platform aims to simplify interactions between regulated companies and the regulatory authority by enabling more efficient handling of regulatory requests and administrative processes.

Through this platform, INVIMA seeks to improve the efficiency of regulatory workflows while strengthening transparency and traceability in regulatory procedures related to regulated products.

InvimÁgil will support several categories of regulated products, including:

  • medicines
  • medical devices
  • cosmetics and personal care products
  • foods and beverages
  • clinical research activities.

A Gradual Implementation Approach

The development and implementation of InvimÁgil follow a phased rollout model, allowing regulatory procedures to be progressively integrated into the platform.

Different product categories and regulatory processes are incorporated gradually, reflecting the complexity of regulatory workflows managed by the authority. This phased approach supports system stability while allowing regulated sectors to progressively adapt to digital regulatory processes.

Why It Matters for Industry

For pharmaceutical and life sciences companies operating in Colombia, digital regulatory platforms such as InvimÁgil represent an important step toward more efficient regulatory interactions with the national authority.

Understanding how regulatory procedures are managed through digital platforms can help organizations prepare internal regulatory workflows, documentation management, and submission processes aligned with INVIMA expectations.

Conclusion

Digital transformation is increasingly shaping how regulatory authorities manage submissions, documentation, and regulatory interactions. In Colombia, platforms such as InvimÁgil illustrate ongoing efforts to improve efficiency, transparency, and traceability across regulatory procedures.

Adapting internal regulatory workflows to platforms like InvimÁgil can represent a significant shift for many pharmaceutical and life sciences organizations. With experience supporting regulatory operations across LATAM, Freyr works alongside companies navigating INVIMA’s digital regulatory environment, aligning documentation, streamlining submissions, and helping organizations adapt their regulatory processes to the authority’s evolving digital systems.